Neovasc Inc. (NVC) Completes Enrollment in COSIRA Trial Assessing Efficacy of Reducer™ Product for Treatment of Refractory Angina
5/13/2013 9:58:29 AM
More...
|
Neovasc Inc. (NVC) Reports Financial Results for 2012 Year-End
4/29/2013 10:59:11 AM
More...
|
Neovasc Inc. (NVC)'s COSIRA Clinical Trial Protocol Selected for Publication in Peer-Reviewed Journal
2/28/2013 10:29:28 AM
More...
|
Neovasc Inc. (NVC) Reports Financial Results for Third Quarter Of 2012
11/26/2012 9:45:32 AM
More...
|
Neovasc Inc. (NVC) Finalizes US $4.6 Million Agreement Giving LeMaitre Vascular, Inc. Rights to In-House Manufacture of Xenosure® Surgical Patch
11/1/2012 10:29:49 AM
More...
|
Neovasc Inc. (NVC)'s Tiara™ Transcatheter Mitral Valve Selected as a "Best" New Device Concept at TCT 2012 Scientific Symposium
10/23/2012 9:58:47 AM
More...
|
Neovasc Inc. (NVC) Announces Upcoming Presentations at TCT 2012 Scientific Symposium
10/18/2012 11:39:42 AM
More...
|
Neovasc Inc. (NVC) Announces LeMaitre Vascular, Inc. Will Accelerate its Acquisition of Rights to In-House Manufacture of Xenosure Product
10/2/2012 10:35:49 AM
More...
|
Neovasc Inc. (NVC) Announces Publication of Tiara Acute Preclinical Data in Journal of American College of Cardiology
9/18/2012 9:45:41 AM
More...
|
Neovasc Inc. (NVC) Reports Financial Results for Second Quarter of 2012
8/9/2012 11:55:46 AM
More...
|
|